Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 2
2004 9
2005 5
2006 9
2007 6
2008 5
2009 7
2010 2
2011 6
2012 5
2013 4
2014 4
2015 7
2016 6
2017 13
2018 3
2019 5
2020 7
2021 8
Text availability
Article attribute
Article type
Publication date

Search Results

107 results
Results by year
Filters applied: . Clear all
Page 1
Evaluation of the effects of dapagliflozin, a sodium-glucose co-transporter-2 inhibitor, on hepatic steatosis and fibrosis using transient elastography in patients with type 2 diabetes and non-alcoholic fatty liver disease.
Shimizu M, Suzuki K, Kato K, Jojima T, Iijima T, Murohisa T, Iijima M, Takekawa H, Usui I, Hiraishi H, Aso Y. Shimizu M, et al. Among authors: aso y. Diabetes Obes Metab. 2019 Feb;21(2):285-292. doi: 10.1111/dom.13520. Epub 2018 Oct 2. Diabetes Obes Metab. 2019. PMID: 30178600 Clinical Trial.
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
Jojima T, Wakamatsu S, Kase M, Iijima T, Maejima Y, Shimomura K, Kogai T, Tomaru T, Usui I, Aso Y. Jojima T, et al. Among authors: aso y. Int J Mol Sci. 2019 Oct 22;20(20):5237. doi: 10.3390/ijms20205237. Int J Mol Sci. 2019. PMID: 31652578 Free PMC article.
Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial.
Ueki K, Sasako T, Okazaki Y, Kato M, Okahata S, Katsuyama H, Haraguchi M, Morita A, Ohashi K, Hara K, Morise A, Izumi K, Ishizuka N, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Ueki K, et al. Lancet Diabetes Endocrinol. 2017 Dec;5(12):951-964. doi: 10.1016/S2213-8587(17)30327-3. Epub 2017 Oct 24. Lancet Diabetes Endocrinol. 2017. PMID: 29079252 Clinical Trial.
[Pioglitazone].
Aso Y. Aso Y. Nihon Rinsho. 2012 May;70 Suppl 3:620-6. Nihon Rinsho. 2012. PMID: 22768588 Japanese. No abstract available.
CD-1db/db mice: A novel type 2 diabetic mouse model with progressive kidney fibrosis.
Mizunuma Y, Kanasaki K, Nitta K, Nakamura Y, Ishigaki Y, Takagaki Y, Kitada M, Li S, Liu H, Li J, Usui I, Aso Y, Koya D. Mizunuma Y, et al. Among authors: aso y. J Diabetes Investig. 2020 Nov;11(6):1470-1481. doi: 10.1111/jdi.13311. Epub 2020 Jul 3. J Diabetes Investig. 2020. PMID: 32472621 Free PMC article.
107 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page